<ul data-eligibleForWebStory="false"><li>Varda Space secures $187 million Series C funding to further development of pharmaceutical manufacturing in space.</li><li>The funding will be used to build a new laboratory facility in California to conduct research on biologics in space.</li><li>Varda aims to solve pharmaceutical manufacturing problems and generate intellectual property by leveraging space-based research.</li><li>Funding led by Natural Capital and Shrug Capital, with contributions from Peter Thiel, Lux Capital, Khosla Ventures, and Caffeinated Capital. Varda has successfully launched and returned three missions since 2023.</li></ul>

With Varda Space, leading Silicon Valley players make big bet on making drugs in space

Discover more